{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Multikinase_Inhibitor_AEE788",
  "nciThesaurus": {
    "casRegistry": "497839-62-0",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "An orally bioavailable multiple-receptor tyrosine kinase inhibitor. AEE788 inhibits phosphorylation of the tyrosine kinases of epidermal growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER2), and vascular endothelial growth factor receptor 2 (VEGF2), resulting in receptor inhibition, the inhibition of cellular proliferation, and induction of tumor cell and tumor-associated endothelial cell apoptosis. (NCI05)",
    "fdaUniiCode": "F9JLR95I3I",
    "identifier": "C48369",
    "preferredName": "Multikinase Inhibitor AEE788",
    "semanticType": "Pharmacologic Substance",
    "subclassOf": [
      "C1967"
    ],
    "synonyms": [
      "AEE 788",
      "AEE-788",
      "AEE788",
      "Multikinase Inhibitor AEE788"
    ]
  }
}